Tigecycline: A glycylcycline antimicrobial agent

Medicine & Life Sciences

• CL 331002 100%
• Tigecycline 79%
• Anti-Infective Agents 59%
• Intraabdominal Infections 17%
• Skin 13%
• Bacterial Small Ribosome Subunits 8%
• Infections 7%
• Drug Information Services 6%
• Pharmacokinetics 6%
• Imipenem Drug Combination Cilastatin 6%
• Tetracycline Resistance 5%
• Aztreonam 5%
• Formularies 5%
• Tetracyclines 5%
• Oxacillin 5%
• Vancomycin-Resistant Enterococci 5%
• Posters 5%
• Bacteroides 5%
• Minocycline 5%
• Phase III Clinical Trials 4%
• Renal Elimination 4%
• Enterobacteriaceae 4%
• Vancomycin 4%
• Liver 4%
• Gram-Negative Bacteria 4%
• United States Food and Drug Administration 4%
• Intravenous Administration 3%
• Abdominal Pain 3%
• Blood Proteins 3%
• Nausea 3%
• In Vitro Techniques 3%
• MEDLINE 3%
• Child 3%
• Vomiting 3%
• Staphylococcus aureus 3%
• Headache 3%
• Communicable Diseases 3%
• Diarrhea 3%
• Pharmaceutical Preparations 3%
• Fever 3%
• Amino Acids 2%
• Clinical Studies 2%
• Clinical Trials 2%
• Peptides 2%
• Drug Therapy 2%
• Kidney 2%
• Therapeutics 2%
• Proteins 1%